BASEL, SWITZERLAND (PRWEB) MARCH 17, 2021 Alan Vanderborght, founder and Chief Executive Officer of KYBORA Group and Chairman of the Board of Directors of KYBORA GmbH, said, “I am thrilled to have Sascha, Eric, and Stephen join our team. Their experience in launching companies, running operations, and the extent of their networks will be of great […]

Read more

PRINCETON, N.J., AND BASEL, SWITZERLAND (PRWEB) MARCH 17, 2021 Alan Vanderborght said, “I am thrilled to have Jean join our team. He brings more than two decades of diversified corporate and business development experience in the pharmaceutical and biotechnology sectors, spanning a broad range of therapeutic areas, asset (biopharma product as well as technology platforms) stages, […]

Read more

PRINCETON, N.J. (PRWEB) MARCH 16, 2021 Alan Vanderborght, Founder and CEO of KYBORA, said: “The opening of KYBORA GmbH is the next phase in KYBORA’s growth. With its inception, we aim to provide high quality M&A, licensing, fundraising, and strategic consulting services to the European pharma and biotech industry. Basel is the ideal location for our […]

Read more

KYBORA is pleased to announce that Anton Leshchenko has joined its team as Managing Director, responsible for expanding KYBORA’s operations in Russia, CIS/CEE, and Africa.  Anton is a senior executive with 18+ years of life science and medical disposables experience with turn around and value addition achievements in territory management and BD&L (both in-/ out-license, […]

Read more

KYBORA is pleased to announce that Rainer Wulf has joined Kybora as a new member of the advisory board. Rainer is a Senior Executive with 30+ years of experience in the pharmaceutical industry, most of them in international positions, starting in sales and followed by Restructuring/Optimization of Sales Organizations, leadership positions in Marketing up to […]

Read more

TYPE & ENTER: